Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Dashboard
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Analytics
Research
CDMO
CRO
Excipients
Pharmaceutical Equipment
Pharmaceutical Intermediates
Supply Chain Logistics
Magazine
Current Issue
Archive
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
Membership Levels
By The Numbers
Zika Virus
11 Articles Available
Can't find what you're looking for? Try our
advanced search
.
Zika
Batavia Biosciences to Deploy Horizon Discovery’s CHO Cell Technology to Develop Anti-Zika Biotherapeutic
PR-M09-19-NI-019
Research
Possible Connection between Dengue Virus Exposure and Zika Virus Infection?
PAO-M03-19-NI-037
Vaccine
Enesi Pharma and Sementis Sign R&D Collaboration Focused on Needle-free Solid Dose Vaccines for Peanut Allergy and Chikungunya/Zika Infection
PR-M11-18-NI-034
Cell and Gene Therapy
Gene that Helps Cells Resist Zika Infection Identified
PAO-M09-18-NI-018
Zika Test
FDA approves additional claim for Roche cobas Zika test
PR-M05-18-NI-061
Drug Development
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development
PR-M02-18-NI-049
Fast Track
FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate
PAO-M02-18-NI-003
Vaccine
Takeda’s Zika Vaccine Candidate Receives U.S. FDA Fast Track Designation
PR-M02-18-NI-003
Clinical Trial
Zika Vaccine Candidate Enters Phase I Trial
PAO-M12-17-NI-008
Zika Virus
Researchers Equipped with New Zika Virus Diagnostic Development Tool
PAO-M08-17-NI-030
Innovation
New Method for Detecting the Zika Virus Developed
PAO-M07-17-NI-033
